| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8774562 | Nefrología | 2018 | 11 Pages |
Abstract
AF in dialysis units is an important finding. Establishing the risk-benefit ratio of anticoagulant treatment constitutes a real challenge. Well-designed clinical trials are pivotal in order to define the rational use of antithrombotic drugs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Carmen Sánchez Perales, Teresa Vázquez Sánchez, Daniel Salas Bravo, Sonia Ortega Anguiano, Eduardo Vázquez Ruiz de Castroviejo,